Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course

K Ahlbeck1, K Fredriksson, O Rooyackers

  • 1Department of Physiology and Pharmacology, Section for Anaesthesiology and Intensive Care Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. karsten.ahlbeck@karolinska.se

Insights

Critical illness polyneuropathy and myopathy (CIPNM) develops early in intensive care units, particularly in patients with sepsis and steroid treatment. Changes in nerve and muscle function appear at different times during mechanical ventilation.

Area of Science:

  • Intensive care medicine
  • Neurology
  • Mitochondrial biology

Background:

  • Critical illness polyneuropathy and myopathy (CIPNM) is a common ICU complication.
  • CIPNM can prolong hospital stays and increase costs.
  • Predisposing factors and temporal patterns of CIPNM are not well understood.

Purpose of the Study:

  • To investigate the time course of CIPNM in critically ill patients.
  • To comprehensively describe changes in neurophysiology, histology, and mitochondrial function.
  • To identify factors associated with CIPNM development.

Main Methods:

  • Studied 10 ICU patients requiring mechanical ventilation.
  • Performed serial neurophysiological, histological, and biochemical analyses over 28 days.
  • Assessed mitochondrial content, respiratory enzymes, and oxidative stress markers.

Main Results:

  • All patients showed neurophysiological abnormalities; 5/5 with sepsis and steroid treatment met CIPNM criteria.
  • CIPNM did not impact patient outcomes.
  • Nerve changes occurred early, while muscle changes appeared later.
  • Decreased citrate synthase and increased mitochondrial superoxide dismutase were observed.

Conclusions:

  • CIPNM signs are detectable early in the ICU course.
  • Sepsis and corticosteroid treatment increase the likelihood of CIPNM.
  • Understanding CIPNM's temporal pattern aids early detection and management.
Abstract

Related Concept Videos

Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...